InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
0.00%
)
US TECH 100
19,326.10
(
-0.04%
)
Dow Jones
42,025.19
(
0.00%
)
Brent Oil
73.85
(
-0.64%
)
Bitcoin
63,076.23
(
0.20%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ash111

Send PM Follow Ignore
Followers 1053
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

ash111

Re: ash111 post# 96812

Wednesday, 05/10/2017 3:21:52 PM

Wednesday, May 10, 2017 3:21:52 PM

Post# of 97239
CBLI 3.3 +10% on a massive volume. coverage: https://www.insiderfinancial.com/cleveland-biolabs-inc-nasdaq-cbli-is-todays-biotech-focus/121534/

"The company showed in the last 10-k that it had about $15 million in total assets and only $3 million in total liabilities. It is also remarkable that the company has no long term debt, and 99% of its assets are short-term investments or cash on hand".

"Conclusion
Cleveland BioLabs is very close to commercializing its new drug Entolimod and has other drugs in Phase 2".

link back to DD

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up